middle.news
How Is Syntara’s Amsulostat Shaping the Future of Blood Cancer Treatment?
2:24pm on Wednesday 30th of July, 2025 AEST
•
Healthcare
Read Story
How Is Syntara’s Amsulostat Shaping the Future of Blood Cancer Treatment?
2:24pm on Wednesday 30th of July, 2025 AEST
Key Points
Positive interim Phase 2 data for amsulostat in myelofibrosis
FDA grants Fast Track designation for amsulostat
Phase 1b/2 trial initiated for amsulostat in myelodysplastic syndrome
First patient dosed in Phase 1c trial for keloid scars
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Syntara (ASX:SNT)
OPEN ARTICLE